Protect Pharmaceutical Corp. (PRTT)
0.25
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
Protect Pharmaceutical Enterprise Value : 14.37M for Aug. 25, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 25, 2026 | 14.37M |
| August 24, 2026 | 14.37M |
| August 21, 2026 | 14.37M |
| August 20, 2026 | 14.37M |
| August 19, 2026 | 19.14M |
| August 18, 2026 | 19.14M |
| August 17, 2026 | 20.11M |
| August 14, 2026 | 17.24M |
| August 13, 2026 | 15.80M |
| August 12, 2026 | 20.89M |
| August 11, 2026 | 20.89M |
| August 10, 2026 | 20.60M |
| August 07, 2026 | 20.11M |
| August 06, 2026 | 17.24M |
| August 05, 2026 | 17.24M |
| August 04, 2026 | 20.11M |
| August 03, 2026 | 19.17M |
| July 31, 2026 | 25.86M |
| July 30, 2026 | 25.86M |
| July 29, 2026 | 25.86M |
| July 28, 2026 | 27.52M |
| July 27, 2026 | 25.86M |
| July 24, 2026 | 25.86M |
| July 23, 2026 | 16.09M |
| July 22, 2026 | 13.79M |
| Date | Value |
|---|---|
| July 21, 2026 | 13.79M |
| July 20, 2026 | 13.79M |
| July 17, 2026 | 13.79M |
| July 16, 2026 | 13.79M |
| July 15, 2026 | 15.52M |
| July 14, 2026 | 15.52M |
| July 13, 2026 | 16.09M |
| July 10, 2026 | 16.09M |
| July 09, 2026 | 16.21M |
| July 08, 2026 | 14.65M |
| July 07, 2026 | 8.049M |
| July 06, 2026 | 8.623M |
| July 02, 2026 | 4.314M |
| July 01, 2026 | 4.314M |
| June 30, 2026 | 4.314M |
| June 29, 2026 | 4.314M |
| June 26, 2026 | 3.453M |
| June 25, 2026 | 3.453M |
| June 24, 2026 | 3.453M |
| June 23, 2026 | 3.453M |
| June 22, 2026 | 3.884M |
| June 18, 2026 | 3.884M |
| June 17, 2026 | 6.325M |
| June 16, 2026 | 6.325M |
| June 15, 2026 | 6.325M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| IGC Pharma, Inc. | 31.92M |
| Cryoport, Inc. | 728.44M |
| Cocrystal Pharma, Inc. | 14.68M |
| CNBX Pharmaceuticals, Inc. | 1.379M |
| GB Sciences, Inc. | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.02M |
| Total Expenses (Quarterly) | 0.02M |
| EPS Diluted (Quarterly) | -0.0004 |
| Earnings Yield | 46.00% |
| Normalized Earnings Yield | 46.00 |